Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5145)
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
8,333
Price
$75.00
Total Value
$624.98K
Shares Held After
0
% of Holdings
100.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,100
Price
$69.69
Total Value
$425.12K
Shares Held After
767,780
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,000
Price
$68.74
Total Value
$137.47K
Shares Held After
773,880
% of Holdings
0.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,500
Price
$67.67
Total Value
$101.51K
Shares Held After
775,880
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
400
Price
$66.37
Total Value
$26.55K
Shares Held After
777,380
% of Holdings
0.1%
INSULET CORP (PODD)
WEATHERMAN ELIZABETH H — Director
Shares
3,450
Price
$144.20
Total Value
$497.49K
Shares Held After
10,352
% of Holdings
33.3%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
29,749
Price
$0.42
Total Value
$12.49K
Shares Held After
482,776
% of Holdings
5.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
9,000
Price
$7.58
Total Value
$68.22K
Shares Held After
75,300
% of Holdings
12.0%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,475
Price
$1.88
Total Value
$6.54K
Shares Held After
95,461
% of Holdings
3.5%
Liquidia Corp (LQDA)
KIRSCH ARTHUR S — Director
Shares
10,000
Price
$54.80
Total Value
$548.00K
Shares Held After
0
% of Holdings
100.0%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
2,400
Price
$1.17
Total Value
$2.81K
Shares Held After
128,404
% of Holdings
1.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,400
Price
$66.75
Total Value
$226.93K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
16,600
Price
$66.31
Total Value
$1.10M
Shares Held After
771,180
% of Holdings
2.1%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
4,866
Price
$15.49
Total Value
$75.37K
Shares Held After
78,416
% of Holdings
5.8%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,866
Price
$15.49
Total Value
$75.37K
Shares Held After
76,039
% of Holdings
6.0%
iRhythm Holdings, Inc. (IRTC)
Rosenbaum Marc Wade — Chief Accounting Officer
Shares
729
Price
$108.19
Total Value
$78.87K
Shares Held After
16,155
% of Holdings
4.3%
iRhythm Holdings, Inc. (IRTC)
Shrishrimal Sumi — EVP, Chief Risk Officer
Shares
1,716
Price
$108.19
Total Value
$185.65K
Shares Held After
40,287
% of Holdings
4.1%
Pulmonx Corp (LUNG)
French Glendon E. III — Director
Shares
13,511
Price
$1.57
Total Value
$21.21K
Shares Held After
1,178,162
% of Holdings
1.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
29,595
Price
$0.45
Total Value
$13.32K
Shares Held After
512,525
% of Holdings
5.5%
Teladoc Health, Inc. (TDOC)
Vandervoort Adam C — CHIEF LEGAL OFFICER, SECRETARY
Shares
7,906
Price
$7.63
Total Value
$60.30K
Shares Held After
110,261
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$543.26
Total Value
$152.11K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$541.68
Total Value
$238.34K
Shares Held After
40,793
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
641
Price
$540.48
Total Value
$346.45K
Shares Held After
41,233
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,310
Price
$539.83
Total Value
$1.25M
Shares Held After
41,874
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,149
Price
$538.81
Total Value
$619.09K
Shares Held After
44,184
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,464
Price
$537.62
Total Value
$787.08K
Shares Held After
45,333
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,056
Price
$536.62
Total Value
$1.10M
Shares Held After
46,797
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$535.69
Total Value
$621.40K
Shares Held After
48,853
% of Holdings
2.3%
Teladoc Health, Inc. (TDOC)
Catapano Joseph Ronald — Chief Accounting Officer
Shares
284
Price
$7.63
Total Value
$2.17K
Shares Held After
10,837
% of Holdings
2.6%
Teladoc Health, Inc. (TDOC)
Bliss Kelly — President, U.S. Group Health
Shares
7,679
Price
$7.63
Total Value
$58.57K
Shares Held After
92,378
% of Holdings
7.7%
Teladoc Health, Inc. (TDOC)
DIVITA CHARLES III — Director
Shares
19,132
Price
$7.63
Total Value
$145.92K
Shares Held After
389,894
% of Holdings
4.7%
Teladoc Health, Inc. (TDOC)
Nueno Carlos — President, International
Shares
6,196
Price
$7.63
Total Value
$47.26K
Shares Held After
57,671
% of Holdings
9.7%
Beta Bionics, Inc. (BBNX)
Mensinger Mike — Chief Product Officer
Shares
4,378
Price
$12.61
Total Value
$55.19K
Shares Held After
184,415
% of Holdings
2.3%
Beta Bionics, Inc. (BBNX)
Feider Stephen — Chief Financial Officer
Shares
6,676
Price
$12.61
Total Value
$84.16K
Shares Held After
166,053
% of Holdings
3.9%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
5,329
Price
$12.61
Total Value
$67.18K
Shares Held After
130,887
% of Holdings
3.9%
Beta Bionics, Inc. (BBNX)
Russell Steven Jon — Chief Medical Officer
Shares
4,222
Price
$12.61
Total Value
$53.23K
Shares Held After
173,849
% of Holdings
2.4%
Beta Bionics, Inc. (BBNX)
Saint Sean — Director
Shares
16,872
Price
$12.61
Total Value
$212.71K
Shares Held After
420,937
% of Holdings
3.9%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
29,000
Price
$0.83
Total Value
$24.15K
Shares Held After
66,167
% of Holdings
43.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
4,500
Price
$7.33
Total Value
$33.00K
Shares Held After
66,300
% of Holdings
6.8%
Fulgent Genetics, Inc. (FLGT)
Xie Jian — President and COO
Shares
2,146
Price
$17.89
Total Value
$38.38K
Shares Held After
367,605
% of Holdings
0.6%
Alector, Inc. (ALEC)
Berkley Neil Lindsay — CFO & Chief Business Officer
Shares
19,360
Price
$1.97
Total Value
$38.22K
Shares Held After
379,900
% of Holdings
4.8%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
5,709
Price
$1.97
Total Value
$11.27K
Shares Held After
98,936
% of Holdings
5.5%
Fulgent Genetics, Inc. (FLGT)
Gao Hanlin — Chief Scientific Officer
Shares
1,688
Price
$17.89
Total Value
$30.19K
Shares Held After
990,374
% of Holdings
0.2%
Alector, Inc. (ALEC)
Rosenthal Arnon — Director
Shares
87,216
Price
$1.97
Total Value
$172.19K
Shares Held After
2,367,206
% of Holdings
3.6%
NovoCure Ltd (NVCR)
HILLEMAN JERYL L — Director
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
13,861
% of Holdings
17.5%
NovoCure Ltd (NVCR)
LEUNG GABRIEL — Director
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
89,499
% of Holdings
3.2%
NovoCure Ltd (NVCR)
VERNON W ANTHONY — Director
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
197,657
% of Holdings
1.5%
NovoCure Ltd (NVCR)
Ocean Allyson J — Director
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
11,324
% of Holdings
20.6%
NovoCure Ltd (NVCR)
Stafford Kristin — Director
Shares
2,945
Price
$15.77
Total Value
$46.44K
Shares Held After
11,324
% of Holdings
20.6%
Progyny, Inc. (PGNY)
Livingston Mark S. — CHIEF FINANCIAL OFFICER
Shares
279
Price
$26.20
Total Value
$7.31K
Shares Held After
78,626
% of Holdings
0.4%
Showing 1–50 of 5145 transactions (page 1 of 103)